Ulcerative Proctitis: Clinical Trials

3 trials for Ulcerative Proctitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated. 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1
Phase 31Completed 1

Follow Ulcerative Proctitis: new trials by email Literature Review of Ulcerative Proctitis trials Research Report on Ulcerative Proctitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Family Members at INcreased-risk for Developing Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC)
RecruitingMassachusetts General Hospital502024-12-182026-10-07
Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories
Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator, Once daily 90 mg hydrocortisone acetate or placebo suppository administered with Sephure applicator, Twice daily placebo suppository administered with Sephure applicator - Ulcerative Proctitis
Phase 3CompletedCristcot HCA LLC2002020-12-102026-08-06
A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis
Niclosamide - Ulcerative Colitis, Ulcerative Proctitis
Phase 1 / Phase 2TerminatedEntero Therapeutics272018-05-152022-11-29

Narrower conditions

Colitis, Ulcerative (2)  ·  Crohn Disease (1)  ·  Inflammatory Bowel Diseases (1)

Broader conditions

Colitis (2)  ·  Colonic Diseases (2)  ·  Digestive System Diseases (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Inflammatory Bowel Diseases (1)

Interventions

Niclosamide (1)  ·  hydrocortisone acetate (1)

Sponsors

Cristcot HCA LLC (1)  ·  Entero Therapeutics (1)  ·  Massachusetts General Hospital (1)

Countries

Italy (2)  ·  United States (2)  ·  Bulgaria (1)  ·  China (1)  ·  Denmark (1)  ·  France (1)  ·  Georgia (1)  ·  Germany (1)  ·  India (1)  ·  Jordan (1)  ·  Lebanon (1)  ·  Libya (1)  ·  Moldova (1)  ·  Philippines (1)  ·  Poland (1)

Top investigators

Emily W Lopes, MD, MPH (1)  ·  James Pennington, M.D. (1)  ·  Jennifer Davagian (1)

NIH funding

2019 (1)